文献速递血液透析通路

编辑精选——导管转换为动静脉通路前预测通路生存的挑战

Editor's Choice - Challenges of Predicting Arteriovenous Access Survival Prior to Conversion from Catheter.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2024-06-09

本研究基于北美大型透析机构的多中心回顾性队列数据,纳入73 031例慢性中心血液透析患者,使用LASSO回归和Boruta结合随机森林分类器两种特征选择与预测流程,预测导管转换为动静脉通路后一年内再转换回导管及全因死亡。结果显示再转换预测的ROCAUC为0.541至0.571,全因死亡预测的ROCAUC为0.662至0.683。结论认为群体层面描绘可能,但个体层面预测性能有限。

要点

  • 再转换回导管的预测模型ROCAUC为0.541至0.571,个体预测性能有限。
  • 全因死亡预测模型ROCAUC为0.662至0.683,作为对照表现较好。
  • 既往动静脉通路失败似乎是后续失败最稳定的预测因素。

核心结论

  • 使用所纳入变量可在群体层面描绘导管转换为动静脉瘘或移植物后的主要不良结局,但个体层面预测性能有限。
  • 瘘创建期间和之后的因素以及生物分子和遗传生物标志物可能是比基线临床状况更相关的瘘生存预测因素。

研究设计与样本

  • 回顾性队列研究,使用北美大型透析机构的多中心数据。
  • 研究人群包括73 031例慢性中心血液透析患者。
  • 数据集包括49个变量,涵盖人口学和临床特征。
  • 使用两种特征选择与预测流程:LASSO回归和Boruta结合随机森林分类器。

主要发现

  • 共38 151例患者(52.2%)具有完整数据,构成主要队列。
  • 在消除缺失数据比例高的变量后,对67 421例患者(92.3%)进行了敏感性分析。
  • 所选特征在不同数据集和流程之间存在差异。
  • 既往动静脉通路失败似乎是后续失败最稳定的预测因素。
  • 基于人口学和临床信息预测再转换的ROCAUC在0.541至0.571之间。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The decision to convert from catheter to arteriovenous access is difficult yet very important. The ability to accurately predict fistula survival prior to surgery would significantly improve the decision making process. Many previously investigated demographic and clinical features have been associated with fistula failure. However, it is not conclusively understood how reliable predictions based on these parameters are at an individual level. The aim of this study was to investigate the probability of arteriovenous fistula maturation and survival after conversion using machine learning workflows. METHODS: A retrospective cohort study on multicentre data from a large North American dialysis organisation was conducted. The study population comprised 73 031 chronic in centre haemodialysis patients. The dataset included 49 variables including demographic and clinical features. Two distinct feature selection and prediction pipelines were used: LASSO regression and Boruta followed by a random forest classifier. Predictions were facilitated for re-conversion to catheter within one year. Additionally, all cause mortality predictions were conducted to serve as a comparator. RESULTS: In total, 38 151 patients (52.2%) had complete data and made up the main cohort. Sensitivity analyses were conducted in 67 421 patients (92.3%) after eliminating variables with a high proportion of missing data points. Selected features diverged between datasets and workflows. A previously failed arteriovenous access appeared to be the most stable predictor for subsequent failure. Prediction of re-conversion based on the demographic and clinical information resulted in an area under the receiver operating characteristic curve (ROCAUC) between 0.541 and 0.571, whereas models predicting all cause mortality performed considerably better (ROCAUC 0.662 - 0.683). CONCLUSION: While group level depiction of major adverse outcomes after catheter to arteriovenous fistula or graft conversion is possible using the included variables, patient level predictions are associated with limited performance. Factors during and after fistula creation as well as biomolecular and genetic biomarkers might be more relevant predictors of fistula survival than baseline clinical conditions.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Hofmann AG, Lama S, Zhang H, et al. Editor's Choice - Challenges of Predicting Arteriovenous Access Survival Prior to Conversion from Catheter. Eur J Vasc Endovasc Surg. 2024. PMID: 38857878. doi:10.1016/j.ejvs.2024.06.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。